glp-1 shortage over The drug is over. What's next for the compounders? - Pharma Technology Focus | Issue 154 GLP-1 Shortage = Over -

While most bacterial membranes consist primarily of saturated or monounsaturated lipids, certain bacteria possess the ability to synthesize PUFAs or acquire them exogenously and incorporate them into their membranes, making ferroptosis-based antimicrobial therapy a promising approach [98,99,100,101]

Mller, D.M., Seim, H., Kiess, W., Lster, H

Neuroprotection Selank : Demonstrates antioxidant effects and supports immune function, protecting neurons from oxidative damage ( 2, 3 )

However, in rare casessuch as patients with kidney disease or specific hereditary disorders related to vitamin B12 metabolismhigh doses or inappropriate use could potentially cause complications